Bio-Works Technologies AB (publ)
SSE:BIOWKS.ST
4.85 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 25.465 | 43.896 | 41.32 | 21.91 | 7.234 | 5.573 | 6.563 | 4.945 | 3.677 | 1.542 |
| Cost of Revenue
| 5.449 | 17.075 | 12.473 | 3.35 | 3.018 | 0.203 | 0.425 | -0.27 | -2.885 | -2.745 |
| Gross Profit
| 20.016 | 26.821 | 28.847 | 18.56 | 4.216 | 5.37 | 6.138 | 5.215 | 6.562 | 4.287 |
| Gross Profit Ratio
| 0.786 | 0.611 | 0.698 | 0.847 | 0.583 | 0.964 | 0.935 | 1.055 | 1.785 | 2.78 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0.232 | 0.253 | 0.419 | 5.2 | 0.566 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 28.35 | 19.78 | 21.127 | 13.975 | 11.562 | 10.639 | 7.976 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0 | 84.325 | 74.946 | 28.35 | 19.78 | 21.127 | 13.975 | 11.562 | 10.639 | 7.976 |
| Other Expenses
| 58.012 | 0 | 75.99 | 1.167 | 30.09 | 26.37 | 30.305 | 17.234 | 12.988 | 8.551 |
| Operating Expenses
| 58.012 | 83.169 | 75.99 | 29.517 | 49.87 | 47.497 | 44.28 | 28.796 | 23.627 | 16.527 |
| Operating Income
| -37.996 | -55.417 | -47.143 | -10.957 | -45.654 | -42.127 | -38.142 | -23.581 | -17.065 | -12.24 |
| Operating Income Ratio
| -1.492 | -1.262 | -1.141 | -0.5 | -6.311 | -7.559 | -5.812 | -4.769 | -4.641 | -7.938 |
| Total Other Income Expenses Net
| 0.715 | 0.683 | 1.401 | 1.588 | 0.635 | 0.015 | -4.447 | -0.076 | -0.066 | -0.121 |
| Income Before Tax
| -37.281 | -54.734 | -44.695 | -9.37 | -45.019 | -42.113 | -37.955 | -23.657 | -17.157 | -12.361 |
| Income Before Tax Ratio
| -1.464 | -1.247 | -1.082 | -0.428 | -6.223 | -7.557 | -5.783 | -4.784 | -4.666 | -8.016 |
| Income Tax Expense
| 0.076 | 2.087 | 0.255 | 3.572 | -0.47 | 0 | 0.189 | 0.022 | 0 | 0 |
| Net Income
| -37.357 | -56.821 | -44.95 | -12.942 | -44.549 | -42.113 | -37.955 | -23.657 | -17.157 | -12.361 |
| Net Income Ratio
| -1.467 | -1.294 | -1.088 | -0.591 | -6.158 | -7.557 | -5.783 | -4.784 | -4.666 | -8.016 |
| EPS
| -0.48 | -1.57 | -1.28 | -0.41 | -1.46 | -1.4 | -1.96 | -1.18 | -0.86 | -0.62 |
| EPS Diluted
| -0.48 | -1.57 | -1.28 | -0.41 | -1.46 | -1.4 | -1.88 | -1.18 | -0.86 | -0.62 |
| EBITDA
| -36.758 | -54.806 | -46.099 | -10.468 | -45.048 | -40.766 | -31.018 | -21.372 | -15.445 | -11.414 |
| EBITDA Ratio
| -1.443 | -1.249 | -1.116 | -0.478 | -6.227 | -7.315 | -4.726 | -4.322 | -4.2 | -7.402 |